申请人:Brubaker Jason
公开号:US20140235641A1
公开(公告)日:2014-08-21
The instant invention provides compounds of formula I which are JAK inhibitors, and as such are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.
本发明提供了I式化合物,它们是JAK抑制剂,因此可用于治疗JAK介导的疾病,如类风湿性关节炎、哮喘、慢性阻塞性肺疾病和癌症。